Raras
Buscar doenças, sintomas, genes...
Miopatia e diabetes mellitus
ORPHA:2596CID-10 · G71.3CID-11 · 8C73.YOMIM 500002DOENÇA RARA

A Miopatia Necrosante Imunomediada (MNI), também denominada "miopatia autoimune associada à estatina" também conhecida como miopatia anti-HMGCR, é uma forma muito rara de dano muscular causado pelo sistema imunológico em pessoas que tomam medicamentos com estatina.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Miopatia e diabetes mellitus é uma condição rara caracterizada por fraqueza muscular progressiva, amiotrofia proximal e alterações nos reflexos. Pode apresentar demência, intolerância ao exercício e sensibilidade vibratória prejudicada, associada a mutações no gene MT-TE.

🏥
SUS: Cobertura mínimaScore: 15%
CID-10: G71.3
🇧🇷Dados SUS / DATASUS
PROCEDIMENTOS SIGTAP (2)
0202010694
Sequenciamento completo do exoma (WES)genetic_test
0301070040
Atendimento em reabilitação — doenças rarasrehabilitation
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

💪
Músculos
15 sintomas
🧠
Neurológico
9 sintomas
🦴
Ossos e articulações
5 sintomas
📏
Crescimento
2 sintomas
🫁
Pulmão
1 sintomas
👂
Ouvidos
1 sintomas

+ 17 sintomas em outras categorias

Características mais comuns

100%prev.
Atraso no desenvolvimento da linguagem
Obrigatório (100%)
100%prev.
Intolerância ao exercício
Frequente (79-30%)
100%prev.
Sinal de Babinski
Frequente (79-30%)
100%prev.
Diabetes mellitus tipo 2
Obrigatório (100%)
100%prev.
Distúrbio da marcha
Obrigatório (100%)
100%prev.
Fraqueza dos músculos do pescoço
Obrigatório (100%)
51sintomas
Muito frequente (12)
Frequente (7)
Ocasional (13)
Muito raro (7)
Sem dados (12)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 51 características clínicas mais associadas, ordenadas por frequência.

Atraso no desenvolvimento da linguagemHP:0025710
Obrigatório (100%)100%
Intolerância ao exercícioExercise intolerance
Frequente (79-30%)100%
Sinal de BabinskiBabinski sign
Frequente (79-30%)100%
Diabetes mellitus tipo 2Type II diabetes mellitus
Obrigatório (100%)100%
Distúrbio da marchaGait disturbance
Obrigatório (100%)100%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Últimos 10 anos200publicações
Pico202592 papers
Linha do tempo
2026Hoje · 2026🧪 1995Primeiro ensaio clínico📈 2025Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

1 gene identificado com associação a esta condição.

Mitochondrial inheritance
MT-TEDisease-causing germline mutation(s) inDesconhecido
LOCALIZAÇÃO

VIAS BIOLÓGICAS (3)
G alpha (i) signalling eventsFormyl peptide receptors bind formyl peptides and many other ligandsG alpha (q) signalling events
OUTRAS DOENÇAS (3)
mitochondrial diseasemitochondrial myopathy with reversible cytochrome C oxidase deficiencymitochondrial myopathy with diabetes
HGNC:7479

Variantes genéticas (ClinVar)

17 variantes patogênicas registradas no ClinVar.

🧬 MT-TE: NC_012920.1:m.8944_15057del ()
🧬 MT-TE: Single allele ()
🧬 MT-TE: NC_012920.1(MT-CYB):m.10950_15540del ()
🧬 MT-TE: NC_012920.1(MT-TE):m.14724G>A ()
🧬 MT-TE: NC_012920.1(MT-TE):m.14739G>A ()
Ver todas no ClinVar

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
3Fase 31
2Fase 21
1Fase 11
·Pré-clínico2
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 5 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Miopatia e diabetes mellitus

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

4 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

0 ensaios clínicos encontrados.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

🥇Melhor nível de evidência: Revisão sistemática
Timeline de publicações
0 papers (10 anos)
#1

Heterogeneous phenotype and cardiovascular comorbidities in Swedish patients with spinobulbar muscular atrophy.

Journal of neurology2026 Jan 10

Spinobulbar muscular atrophy (SBMA) is an X-linked neuromuscular disorder characterized by adult-onset progressive muscle atrophy, flaccid paresis, and bulbar palsy. In addition, increasing evidence indicates that SBMA is a multisystem disorder with prominent non-motor symptoms, such as sensory neuropathy, androgen insensitivity, and glucose intolerance. This study aimed to further characterize the clinical manifestations and biomarker profile in a large Swedish SBMA cohort. 49 genetically confirmed SBMA patients were identified from a motor neuron disease database at Umeå University Hospital, Sweden. CAG repeat length in the androgen receptor (AR) gene was assessed by RP-PCR. Blood samples were analyzed for cardiovascular and muscle biomarkers. Clinical data were collected from medical records and interviews, with autopsy findings reviewed in two cases. The mean CAG repeat length was 43.1, with a mean age at motor symptom onset of 58.6 years. Notably, 19% of patients initially presented with sensory symptoms. High prevalence of hypertonia (70%), diabetes mellitus (39%), and cardiac disease (38%) was observed. Elevated troponin levels were common, and pNfL (neurofilament light chain in plasma) was elevated in seven patients, likely reflecting combined cerebrovascular and cardiovascular comorbidity. Importantly, two of these seven patients exhibited rapid disease progression, and a concomitant diagnosis of ALS was confirmed histopathologically. This cohort was characterized by a relatively low number of AR gene CAG repeats and a late onset of motor symptoms. Sensory symptoms frequently occurred before motor decline. Cardiovascular disease and diabetes were common comorbidities and, in some cases, preceded neurological symptoms. These findings underscore the need for improved clinical awareness of the heterogeneous presentation of SBMA and support routine cardiovascular monitoring to reduce diagnostic delays and prevent early mortality.

#2

Effectiveness and Safety of Statins in Type 2 Diabetes According to Baseline Cardiovascular Risk : A Target Trial Emulation Study.

Annals of internal medicine2026 Feb

Whether statins benefit patients with type 2 diabetes mellitus (T2DM) with low predicted 10-year cardiovascular risk is uncertain. To evaluate the effectiveness and safety of statin initiation for primary prevention among adults with T2DM stratified by predicted 10-year risk for cardiovascular disease (CVD). Cohort study using target trial emulation. U.K. primary care using the IQVIA Medical Research Data database. Persons aged 25 to 84 years with a diagnosis of T2DM between 2005 and 2016 and no history of coronary artery disease, myocardial infarction, stroke, heart failure, myopathy, liver disease, rheumatic heart disease, schizophrenia, or cancer. Statin initiation versus noninitiation, with estimation of the observational analogues of the intention-to-treat effect. Statin initiators were propensity score-matched to noninitiators in a 1:4 ratio within 4 QRISK3 strata of 10-year predicted cardiovascular risk: low (<10%), intermediate (10% to 19%), high (20% to 29%), and very high (≥30%). Absolute risk differences (RDs) and risk ratios (RRs) at 10 years of follow-up for all-cause mortality and major CVD, as well as myopathy and liver dysfunction. Statin initiation was associated with reductions in all-cause mortality and major CVD across QRISK3 strata. In the low-risk stratum, RDs and RRs were -0.53% (95% CI, -0.90% to -0.08%) and 0.80 (95% CI, 0.67 to 0.97), respectively, for all-cause mortality and -0.83% (95% CI, -1.28% to -0.34%) and 0.78 (95% CI, 0.66 to 0.91), respectively, for major CVD. A small increased risk for myopathy was observed in the moderate-risk stratum only, and there was no associated increased risk for liver dysfunction in any stratum. Unmeasured confounding and underascertainment of some hospitalization outcomes. Statin use in T2DM for primary prevention was associated with reductions in all-cause mortality and major CVD across the full spectrum of predicted cardiovascular risk. National Natural Science Foundation of China.

#3

Role of LPC 18:1 in the Lipid Metabolic Response to Combined Vitamin D and Resistance Exercise for Protecting Diabetic Skeletal Muscle Function.

Medicine and science in sports and exercise2026 Jan 01

We have previously found that vitamin D and resistance exercise synergistically improve type 2 diabetes mellitus (T2DM)-related skeletal muscle atrophy. This study aims to investigate the effect of varying exercise intensity on synergistic effects of vitamin D and resistance exercise on their efficacy in improving T2DM-induced myopathy and to further elucidate the underlying mechanism. We compared the effects of vitamin D combined with low-, moderate-, and high-intensity resistance exercise on metabolic status and skeletal muscle function. Then, we explored the mechanism through lipidomic analysis in diabetic rats and verified in adults with T2DM. We found that combined intervention of vitamin D and medium-resistivity volume (MRV) exercise most effectively improved glucose metabolism and insulin sensitivity and increased muscular mass and strength, resulting to alleviated gastrocnemius muscle atrophy in diabetic rats. Vitamin D combined with MRV intervention increased expressions of vitamin D receptor, whereas lysophosphatidylcholine acyltransferase 3, activated p38 MAPK, and ERK1/2 signaling pathways suppressed inflammatory responses. Moreover, lipidomic analysis of gastrocnemius muscle indicated that lysophosphatidylcholine (LPC) 18:1 exhibited the most significant restoration after intervention. Notably, in adults with T2DM, reduced changes in plasma LPC 18:1 levels exhibited positive correlations with decreased appendicular skeletal muscle index, upper limb muscle mass, and thigh muscle mass. Our findings suggested that vitamin D combined with MRV intervention has more pronounced effect on improving T2DM-related skeletal muscle atrophy. Additionally, LPC 18:1 may be a key target for regulating skeletal muscle function through p38 MAPK/ERK and inflammatory signaling pathways. These results provide novel insights for the prevention and treatment of T2DM-related skeletal muscle atrophy through lifestyle modifications.

#4

Effects of Diactive-1-Supported Progressive Resistance Training on Body Composition in Youth With Type 1 Diabetes.

Journal of cachexia, sarcopenia and muscle2026 Apr

Compared to their healthy peers, children and adolescents with type 1 diabetes are at an increased risk of adverse changes in body composition, including increased fat mass along with reductions in lean and bone mass. Although exercise has shown promise in improving body mass index in this population, the individual effects of resistance training on specific body composition parameters remain understudied. The aim of the study was to evaluate the effects of resistance training supported by the mHealth application Diactive-1 on body composition in children and adolescents with type 1 diabetes. Sixty-two participants with type 1 diabetes (aged 8-18 years old; 48% females) participated in a 24-week randomised controlled trial and were assigned to either the usual care group (n = 32) or the exercise group (n = 30). The intervention was delivered via the Diactive-1 app, which generates progressive overload resistance training programmes tailored to real-time glycaemia and provides educational support. Body composition was assessed using anthropometry and dual-energy X-ray absorptiometry, with fat, lean and bone measurements standardised by age, sex and ethnicity. Linear mixed models were used to evaluate between-group differences in change over time under both intention-to-treat (ITT) and per-protocol (PP) approaches. At 24 weeks, in the ITT analysis, the intervention group showed greater gains in lean mass (mean difference [MD] = 0.88 kg; 95% confidence interval [CI] 0.09 to 1.66; Hedges' g = 0.568) and whole-body bone mineral content less head (MD = 32.40 g; 95% CI 6.90 to 57.89; g = 0.644) compared with those in the usual care group. No changes were observed in anthropometric measures, fat mass-related regions or standardised variables (p > 0.05). The risk of probable sarcopenia was lower in the intervention group (relative risk [RR] = 0.17; 95% CI 0.04 to 0.73; Cohen's h = 0.987) than in the usual care group. Findings were directionally consistent in the PP analysis. This intervention increased bone-related outcomes and was associated with modest gains in lean mass and a lower risk of probable sarcopenia in youths with type 1 diabetes. These findings highlight the potential of the Diactive-1 app as an adjunct tool to support musculoskeletal health in youths with type 1 diabetes. ClinicalTrials.gov identifier: NCT06048757.

#5

HMGB1: a key molecule linking chronic inflammation to complications in type 2 diabetes mellitus and a target for exercise intervention.

Frontiers in endocrinology2026

The pathological process of type 2 diabetes mellitus (T2DM) is closely associated with chronic low-grade inflammation. High mobility group box 1 (HMGB1), a key damage-associated molecular pattern (DAMP), is frequently dysregulated in T2DM and is implicated in promoting insulin resistance (IR), β cell dysfunction, and the progression of multiple complications-including cardiovascular disease, nephropathy, cognitive impairment, myopathy, and dyslipidemia-primarily through activating signaling pathways such as RAGE/TLR4-NF-κB. Exercise, a cornerstone non-pharmacological intervention, effectively mitigates HMGB1-driven pathology through multifaceted mechanisms. These include direct downregulation of HMGB1 expression and suppression of its downstream inflammatory pathways, as well as indirect effects via improved glycemic control, enhancing autophagy, and reduced oxidative stress. This review aims to systematically examine the evidence for the role of HMGB1 in T2DM pathogenesis and its complications, and to evaluate exercise as a potential strategy to target this inflammatory pathway, thereby providing a theoretical framework for future therapeutic approaches.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC3 artigos no totalmostrando 199

2026

Effects of Diactive-1-Supported Progressive Resistance Training on Body Composition in Youth With Type 1 Diabetes.

Journal of cachexia, sarcopenia and muscle
2026

HMGB1: a key molecule linking chronic inflammation to complications in type 2 diabetes mellitus and a target for exercise intervention.

Frontiers in endocrinology
2026

Statin Therapy for Primary Prevention and Clinical Outcomes in Adults Aged 80 and Older: A Retrospective Comparative Cohort Study.

Journal of the American Geriatrics Society
2026

Endoplasmic reticulum stress in skeletal muscle dysfunction of type 2 diabetes: mechanisms and therapeutic implications.

Frontiers in endocrinology
2026

A severe case of rhabdomyolysis, acute kidney injury, cardiogenic shock, and chronic complications caused by an excessively large dose of Tripterygium glycoside.

International immunopharmacology
2026

Left Atrial Strain as a Marker of Supraventricular Arrhythmia Risk in Type 2 Diabetes Mellitus.

Diseases (Basel, Switzerland)
2026

Erythematous rash and proximal muscle weakness in a 59-year-old woman: Delayed diagnosis of dermatomyositis in a patient with skin of color.

Journal of the National Medical Association
2026

Clinical importance of simple muscular fitness tests to predict long-term health conditions: a systematic review and meta-analysis of 94 cohort studies.

British journal of sports medicine
2026

Efficacy and side effect of transcatheter arterial embolization using a novel embolic agent for lateral epicondylitis in a diabetic patient: A case report.

Medicine
2026

Mitochondrial Myopathy, Lactic Acidosis, and Stroke-Like Episodes Combined with Diabetes: A Case Report.

Endocrine, metabolic &amp; immune disorders drug targets
2026

Exploring the effects of GLP-1 receptor agonists in fibromyalgia: a propensity-matched real-world cohort using the TriNetX research platform.

Rheumatology (Oxford, England)
2026

Heterogeneous phenotype and cardiovascular comorbidities in Swedish patients with spinobulbar muscular atrophy.

Journal of neurology
2026

Sodium-Glucose Cotransporter 2 Inhibitors and Reduced Fibromyalgia Risk in Patients With Diabetes: A Target Trial Emulation Study.

In vivo (Athens, Greece)
2026

Glucagon-Like Peptide 1 Receptor Agonists, Sodium-Glucose Cotransporter 2 Inhibitors, and Risk of Autoimmune Rheumatic Diseases.

Arthritis &amp; rheumatology (Hoboken, N.J.)
2026

Effectiveness and Safety of Statins in Type 2 Diabetes According to Baseline Cardiovascular Risk : A Target Trial Emulation Study.

Annals of internal medicine
2025

The HMGB1/RAGE/β-catenin axis mediates aberrant osteogenic-tenogenic differentiation imbalance of tendon stem/progenitor cells in diabetic tendinopathy.

Journal of orthopaedic surgery and research
2025

Insulin Deficiency Exacerbates Muscle Atrophy and Osteopenia in Chrebp Knockout Mice.

International journal of molecular sciences
2026

Swimming exercise attenuates diabetic myopathy and is associated with histological and mitochondrial changes in pregnant rats (Rattus norvegicus).

Biochimica et biophysica acta. Molecular basis of disease
2025

Anemarrhena asphodeloides-derived small extracellular vesicle ameliorate diabetes-induced muscle atrophy via activating Pink1-mediated mitophagy.

Phytomedicine : international journal of phytotherapy and phytopharmacology
2026

Endocrine Comorbidities in Fibromyalgia.

Clinical endocrinology
2025

Reduced Muscular Carnosine in Proximal Myotonic Myopathy-A Pilot 1H-MRS Study.

Annals of clinical and translational neurology
2026

Male infertility and risk of cardiometabolic conditions: a population-based cohort study.

Human reproduction (Oxford, England)
2026

Negative Impact of Diabetic Polyneuropathy on Muscle Weakness in the Lower Extremities of Older Patients Undergoing Coronary Artery Bypass Graft Surgery: A Retrospective Cohort Study.

Journal of geriatric physical therapy (2001)
2026

Increased prevalence and incidence of statin-associated immune-mediated necrotizing myopathy in Native Americans.

Rheumatology (Oxford, England)
2025

Effects of a moderate combined exercise program on cognitive function, quality of life, and glycemic profile in older adults with type II diabetes mellitus.

Clinics (Sao Paulo, Brazil)
2025

A Robust Multivariate Approach Unveils a 1H-NMR-Based Spectral Metabolomics Signature Predictive of Cardiovascular Disease in People with Type 2 Diabetes: A Prospective [email protected] Cohort Study.

Journal of proteome research
2025

[Aggressive course of ectopic ACTH syndrome due to adrenal medulla hyperplasia. Case report].

Terapevticheskii arkhiv
2025

A rare case of H syndrome with severe multisystem involvement: Clinical challenges in low-resource healthcare settings.

The Journal of international medical research
2025

Hyperbaric Oxygenation Therapy as Adjunctive Treatment of Complex Wound Associated with Sterno-clavicular Septic Arthritis.

Undersea &amp; hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc
2025

Statin-Associated Immune-Mediated Necrotizing Myopathy With Dual Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase (Anti-HMGCR) and Anti-OJ Positivity: A Case Report of Fulminant Weakness and Respiratory Failure.

Cureus
2025

Low muscle strength and mortality: Key risk factors in the National Health and Nutrition Examination Survey retrospective cohort study.

Medicine
2025

Muscle-Bone Crosstalk and Metabolic Dysregulation in Children and Young People Affected with Type 1 Diabetes: Mechanisms and Clinical Implications.

Cells
2025

[Multiple pyomyositis and prostatic abscess in a patient with poorly controlled diabetes mellitus].

Medicina
2026

Amelioration of diabetic myopathy by APMCG-1: A mountain-cultivated ginseng-derived glycopeptide evaluated in zebrafish and mouse models.

Journal of ethnopharmacology
2025

Unraveling the causality between carpal tunnel syndrome and trigger finger through genetic instrumental variables.

European journal of medical research
2025

Morphofunctional parameters as predictors of autologous hematopoietic stem cell transplantation outcomes.

Frontiers in nutrition
2025

Myosteatosis and Type 2 Diabetes Mellitus.

Acta medica (Hradec Kralove)
2025

Prevalence of Musculoskeletal Disorders Among People Living With Type 2 Diabetes in the Western Region of Saudi Arabia: A Cross-Sectional Study.

Cureus
2025

Advanced Gene-Expression Analysis of Skeletal Muscles Focusing on Normal, Glucose-Intolerant, and Diabetic Individuals with Type 2 Diabetes.

Biomedicines
2025

Factitiously Low Total Creatine Kinase Activity in Severe Rhabdomyolysis: A Case Series.

Prague medical report
2026

MRI characteristics of plantar fibromas: a large consecutive series from a tertiary care center with symptom analysis.

Skeletal radiology
2025

Molecular and Immunomodulatory Mechanisms of Statins in Inflammation and Cancer Therapeutics with Emphasis on the NF-κB, NLRP3 Inflammasome, and Cytokine Regulatory Axes.

International journal of molecular sciences
2026

Comparison of Ultrasonographic Features Among Healthy Individuals and Patients With Trigger Finger.

Journal of clinical ultrasound : JCU
2025

Safety and Effectiveness of Statins for Primary Prevention in Adults With Type 1 Diabetes: An Emulation.

Journal of the American College of Cardiology
2025

Association between diabetic peripheral neuropathy and lower limb muscle strength in patients with type 2 diabetes mellitus: A systematic review and meta-analysis.

Journal of diabetes investigation
2026

Role of LPC 18:1 in the Lipid Metabolic Response to Combined Vitamin D and Resistance Exercise for Protecting Diabetic Skeletal Muscle Function.

Medicine and science in sports and exercise
2025

A comprehensive MRI-based study on adhesive capsulitis and its correlations with tendinosis and systemic diseases.

Radiologie (Heidelberg, Germany)
2025

Musculoskeletal pain in an ageing population: a cross-sectional analysis of the Maastricht study.

Rheumatology international
2024

My patient is taking a statin and is scheduled for surgery.

Casopis lekaru ceskych
2025

Comorbid pathologies and their impact on progressive supranuclear palsy: current view.

Journal of neural transmission (Vienna, Austria : 1996)
2025

The most common diagnoses in primary care, and changes over time, in the total population of Stockholm, Sweden.

BMC primary care
2025

Effect of sodium-glucose cotransporter-2 inhibitors on skeletal muscle.

European journal of internal medicine
2025

[A case of recurrent cerebellitis leading to the diagnosis of mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS)].

Rinsho shinkeigaku = Clinical neurology
2025

Orbital necrotizing fasciitis due to Prevotella baroniae resulting in acute orbital compartment syndrome.

Orbit (Amsterdam, Netherlands)
2025

Mechanisms of skeletal muscle atrophy in type 2 diabetes mellitus.

Frontiers in physiology
2025

Frequency, diagnosis, and management of polymyalgia rheumatica in Germany-database analysis of medical insurance data.

Rheumatology (Oxford, England)
2025

The value of ultrasound in the evaluation of the type 2 diabetes mellitus related plantar fascia changes.

Clinical hemorheology and microcirculation
2025

Incretin-based therapy: An update focusing on the major revolution in cardiovascular-kidney-metabolic health.

Journal of the Chinese Medical Association : JCMA
2025

Bi-allelic loss-of-function variants in POC5 cause a syndromic retinal, endocrine, and neuromuscular ciliopathy.

Genetics in medicine : official journal of the American College of Medical Genetics
2025

Upper-Limb Complications in Diabetes: A Narrative Review.

Diabetes care
2025

How Does Tendon Region, Donor, and the Presence of Disease Affect Protein Composition of the Achilles Tendon?

Clinical orthopaedics and related research
2025

Skeletal Muscle Ultrasound Radiomics and Machine Learning for the Earlier Detection of Type 2 Diabetes Mellitus.

Journal of medical ultrasound
2025

Statin-associated immune-mediated necrotizing myopathy in Hispanic Americans.

Seminars in arthritis and rheumatism
2025

Acute Kidney Injury and Chronic Kidney Disease Associated with a Genetic Defect: A Report of Two Cases.

International journal of molecular sciences
2025

The simple task of lifting five kilograms serves as a predictor of age-related disorders in old adults.

Scientific reports
2025

Involvement of impaired carnitine-induced fatty acid oxidation in experimental and human diabetic kidney disease.

JCI insight
2025

Efficacy and Safety of Prolonged Treatment with Pemafibrate plus an HMG-CoA Reductase Inhibitor in Japanese Patients with Type 2 Diabetes Mellitus.

Drug research
2025

Endocrine manifestations and long-term outcomes of patients with mitochondrial diseases.

Orphanet journal of rare diseases
2025

p16INK4a downregulation alleviates temporomandibular joint osteoarthritis combined with type 2 diabetes by driving M2 polarization.

Biomedicine &amp; pharmacotherapy = Biomedecine &amp; pharmacotherapie
2025

β-hydroxybutyrate attenuates diabetic renal and muscular pathologies in a streptozotocin-induced diabetic model.

Nutrition (Burbank, Los Angeles County, Calif.)
2025

Hemoadsorption combined with continuous venovenous hemodialyfiltration in a patient with Escherichia coli infection and severe diabetic ketoacidosis-associated rhabdomyolysis: A case report.

The Journal of international medical research
2025

Novel and Ultrarare Heterozygous Missense LMNA Variants Causing Familial Partial Lipodystrophy.

The Journal of clinical endocrinology and metabolism
2025

Comparative Effectiveness and Safety of Moderate-Intensity Pravastatin Versus Atorvastatin in Patients with Dyslipidemia: A Retrospective Cohort Study Using a Common Data Model of Multicenter Electronic Health Records in South Korea.

Journal of atherosclerosis and thrombosis
2025

Patients with overlapping dermatomyositis and psoriasis: an experience from a tertiary center and review of the literature.

Advances in rheumatology (London, England)
2025

Crossed Cerebellar Diaschisis in a Patient with MELAS Syndrome: A Case Report.

Cerebellum (London, England)
2025

Carnitine Deficiency Caused by Salcaprozic Acid Sodium Contained in Oral Semaglutide in a Patient with Multiple Acyl-CoA Dehydrogenase Deficiency.

International journal of molecular sciences
2025

Maternal Physical Activity, Fitness, and Body Composition in Women with Gestational Diabetes: A Prospective Study.

Medicine and science in sports and exercise
2025

Diabetic Myonecrosis: Lessons in Recognizing and Treating a Rare Complication.

Journal of investigative medicine high impact case reports
2025

Beyond Bone Remodeling: Denosumab's Multisystemic Benefits in Musculoskeletal Health, Metabolism, and Age-Related Diseases-A Narrative Review.

Biomedicines
2025

Diverse Phenotypes of Mitochondrial Disease With Varying Levels of Heteroplasmy.

JCEM case reports
2025

Role of DPP-4 and NPY Family Peptides in Gastrointestinal Symptoms Associated with Obesity and Type 2 Diabetes Mellitus.

Medicina (Kaunas, Lithuania)
2025

Impact of vitamin D and vitamin D receptor activator in diabetic nephropathy.

Frontiers in clinical diabetes and healthcare
2025

Cardiovascular risk and cardiac involvement in idiopathic inflammatory myopathies: insights from a cross-sectional Swedish single-centre study.

Scandinavian journal of rheumatology
2025

Retinopathy associated with MELAS syndrome. A case report.

Archivos de la Sociedad Espanola de Oftalmologia
2025

High-intensity interval training alleviates STZ-induced muscle atrophy by restoration of nuclear positioning defects in C57BL/6 male mice.

Scientific reports
2025

New Insights on the miRNA Role in Diabetic Tendinopathy: Adipose-Derived Mesenchymal Stem Cell Conditioned Medium as a Potential Innovative Epigenetic-Based Therapy for Tendon Healing.

Biomolecules
2025

Deuterium-reinforced polyunsaturated fatty acids protect against muscle atrophy by STZ-induced diabetic mice.

Free radical biology &amp; medicine
2025

Characteristics of Overlap Syndrome in a Large Cohort of Brazilian Patients With Systemic Sclerosis: A Retrospective Analysis.

The Journal of rheumatology
2026

Is Obesity a Risk Factor for Developing Trigger Finger? A Case-Control Analysis of 198 804 Patients.

Hand (New York, N.Y.)
2025

Polyphenol-Modified Mg-Zn Layered Hydroxide-Contained Microneedle Patch Enhance Mucosal Repair by Remolding Diabetic Oral Microenvironment.

Advanced healthcare materials
2025

Feasibility challenges in protein supplementation research: Insights from the convalescence of functional outcomes after intensive care unit stay in a Randomised Controlled Trial.

Clinical nutrition (Edinburgh, Scotland)
2026

Physiological mechanisms of neuromuscular impairment in diabetes-related complications: Can physical exercise help prevent it?

The Journal of physiology
2025

Two Concerns and A Single Solution in Managing Type 2 Diabetes: A Narrative Review on Imeglimin.

The Journal of the Association of Physicians of India
2025

The association of muscle weakness with functional disability in older patients with Diabetes mellitus: Measured by three different grip strength thresholds.

PloS one
2025

Exploring the relationship between glycemic variability and muscle dysfunction in adults with diabetes: A systematic review.

Reviews in endocrine &amp; metabolic disorders
2025

Aptamer-Conjugated Exosomes Ameliorate Diabetes-Induced Muscle Atrophy by Enhancing SIRT1/FoxO1/3a-Mediated Mitochondrial Function.

Journal of cachexia, sarcopenia and muscle
2025

Enhancing diabetic muscle repair through W-GA nanodots: a nanomedicinal approach to ameliorate myopathy in type 2 diabetes.

Burns &amp; trauma
2025

The Role of microRNA-22 in Metabolism.

International journal of molecular sciences
2025

Type 2 Diabetes Induces Mitochondrial Dysfunction in Zebrafish Skeletal Muscle Leading to Diabetic Myopathy via the miR-139-5p/NAMPT Pathway.

International journal of molecular sciences
2025

Skeletal muscle disorders as risk factors for type 2 diabetes.

Molecular and cellular endocrinology
2025

ICAM1 blockade improves ischemic muscle reperfusion in diabetic mice.

Cardiovascular diabetology
2025

The Predictors of Dietary Supplement Use Among Women With Musculoskeletal Disease: A Population-Based Complex Sample Designed Study.

Inquiry : a journal of medical care organization, provision and financing
2025

A novel technique for external iliac artery reconstruction in renal transplant patients with extensively atherosclerotic lower limb vasculature.

Journal of vascular surgery cases and innovative techniques
2025

Timing of resistance exercise and cardiometabolic outcomes in adults with prediabetes: a secondary analysis.

Journal of applied physiology (Bethesda, Md. : 1985)
2025

Association between cardiometabolic diseases and the risk and progression of motor neuron diseases in Sweden: a population-based case-control study.

The Lancet regional health. Europe
2025

Anti-VEGF therapy for proliferative diabetic retinopathy in Kearns-Sayre syndrome.

Documenta ophthalmologica. Advances in ophthalmology
2024

Secondary Polymyalgia Rheumatica Following SARS-CoV-2 Infection.

Acta medica Okayama
2026

Thyrotoxic Hypokalemic Periodic Paralysis Induced by High-Dose Insulin in an Adolescent Male with Type 1 Diabetes Mellitus.

Hormone research in paediatrics
2024

Regulation of injury-induced skeletal myofiber regeneration by glucose transporter 4 (GLUT4).

Skeletal muscle
2024

Hypermucoviscous Klebsiella pneumoniae presenting as sternocleidomastoid pyomyositis with subsequent lower extremity necrotising fasciitis.

BMJ case reports
2025

Development of a natural rubber latex-based biodevice with mesenchymal stem cells as a potential treatment for skeletal muscle regeneration in gestational diabetes-induced myopathy.

International journal of biological macromolecules
2025

Real-world safety evaluation of atorvastatin: insights from the US FDA adverse event reporting system (FAERS).

Expert opinion on drug safety
2025

Altered sphingolipid profile in response to skeletal muscle injury in a mouse model of type 1 diabetes mellitus.

American journal of physiology. Cell physiology
2025

The Stimulator of Interferon Genes Deficiency Attenuates Diabetic Myopathy Through Inhibiting NLRP3-Mediated Pyroptosis.

Journal of cachexia, sarcopenia and muscle
2025

Muscle regeneration and muscle stem cells in metabolic disease.

Free radical biology &amp; medicine
2024

[Negative pressure therapy as complementary treatment in tropical diabetic hand syndrome].

Revista medica del Instituto Mexicano del Seguro Social
2025

Exploring differential miRNA expression profiles in muscular and visceral adipose tissue of patients with severe obesity.

International journal of obesity (2005)
2024

Investigating the mechanism of supraspinatus tendinopathy induced by type 2 diabetes mellitus in rats using untargeted metabolomics analysis.

BMC musculoskeletal disorders
2024

Baicalein Ameliorates Insulin Resistance of HFD/STZ Mice Through Activating PI3K/AKT Signal Pathway of Liver and Skeletal Muscle in a GLP-1R-Dependent Manner.

Antioxidants (Basel, Switzerland)
2024

Increased risk of adverse events among patients with vs. without systemic autoimmune rheumatic disease prescribed sodium-glucose cotransporter 2 inhibitors: a retrospective cohort study.

Clinical rheumatology
2024

No Muscle Left Behind: Cardiac Arrest and Myocarditis in a Patient With Idiopathic Inflammatory Myopathy.

Cureus
2024

Phenotypic and molecular reanalysis of a cohort of patients with monogenic diabetes reveals a case of partial lipodystrophy due to the A8344G mutation in the mitochondrial DNA.

Archives of endocrinology and metabolism
2024

Study of Rates and Factors Associated to Psychosomatic Syndromes Assessed Using the Diagnostic Criteria for Psychosomatic Research across Different Clinical Settings.

Psychotherapy and psychosomatics
2024

Metformin modulates the TXNIP-NLRP3-GSDMD pathway to improve diabetic bladder dysfunction.

Scientific reports
2024

[The diabetic hand - a forgotten complication].

Lakartidningen
2024

Deciphering the Role of Maternal Microchimerism in Offspring Autoimmunity: A Narrative Review.

Medicina (Kaunas, Lithuania)
2024

[Dupuytren's disease : Epidemiology, diagnosis, treatment, outcome].

Orthopadie (Heidelberg, Germany)
2024

Tropical Myositis: A Not-So-Tropical Diagnosis in a Febrile Type 1 Diabetic Patient.

WMJ : official publication of the State Medical Society of Wisconsin
2024

Fenofibrate to prevent amputation and reduce vascular complications in patients with diabetes: FENO-PREVENT.

Cardiovascular diabetology
2024

Exploring the Overlooked Depression, Anxiety, Insomnia and Fibromyalgia Syndrome Burden in Arab Women with Type 2 Diabetes: New Avenues for Chronic Disease Management.

Medicina (Kaunas, Lithuania)
2024

Wolfram Syndrome 1: A Neuropsychiatric Perspective on a Rare Disease.

Genes
2024

Strategies to Address Statin Medication Intolerance Among Patients at Risk of Cardiovascular Disease Identified Through Electronic Health Records: A Literature Review and Pooled Analysis.

Studies in health technology and informatics
2025

LONG-TERM FOLLOW-UP OF A FAMILY WITH A3243G MITOCHONDRIAL SYNDROME.

Retinal cases &amp; brief reports
2024

Data-independent LC-MS/MS analysis of ME/CFS plasma reveals a dysregulated coagulation system, endothelial dysfunction, downregulation of complement machinery.

Cardiovascular diabetology
2025

Ultrasonographic findings in diabetic cheiroarthropathy: a pilot study.

Scandinavian journal of rheumatology
2024

Responsible Use of Oral Corticosteroids in People with Comorbid Diabetes: An Expert Consensus.

The Journal of the Association of Physicians of India
2025

Diabetes with GLP-1R polymorphism (rs3765467) accompanied by myotonic dystrophy: A case of myotonic dystrophy with p.R131Q polymorphism at the glucagon-like peptide-1 receptor (rs3765467) resulting in marked effects of its agonist, dulaglutide.

The American journal of the medical sciences
2024

[A case report of a MODY 10 family presenting as hypokalemic periodic paralysis].

Zhonghua nei ke za zhi
2024

Shoulder muscle weakness and proprioceptive impairments in type 2 diabetes mellitus: exploring correlations for improved clinical management.

PeerJ
2024

Systemic Deletion of ARRDC4 Improves Cardiac Reserve and Exercise Capacity in Diabetes.

Circulation research
2024

Diabetic myonecrosis complicated by emphysematous pyomyositis and abscess caused by Escherichia coli: a case report.

Journal of medical case reports
2025

A case of extraocular muscle pyomyositis in an elderly patient with diabetes mellitus.

Orbit (Amsterdam, Netherlands)
2024

Effect of fibromyalgia on demographic, biochemical, metabolic and inflammatory profiles: a single-centre retrospective study.

Clinical and experimental rheumatology
2024

Contribution of circulating Mfge8 to human T2DM and cardiovascular disease.

Gene
2024

Inflammatory-mediated atrial cardiomyopathy diagnosed using multimodality imaging and successfully treated with prednisolone: a case report.

European heart journal. Case reports
2024

Comparative study on muscle function in two different streptozotocin-induced diabetic models.

Acta diabetologica
2024

Type 2 diabetes mellitus related sarcopenia: a type of muscle loss distinct from sarcopenia and disuse muscle atrophy.

Frontiers in endocrinology
2024

Clinical Progression and Manifestations of H Syndrome: A Case Report of Failed Treatment Option.

The American journal of case reports
2024

Sarcopenia Prevalence among Hospitalized Patients with Severe Obesity: An Observational Study.

Journal of clinical medicine
2024

An RNA-seq study in Friedreich ataxia patients identified hsa-miR-148a-3p as a putative prognostic biomarker of the disease.

Human genomics
2024

Identifying non-genetic factors associated with trigger finger.

Journal of plastic, reconstructive &amp; aesthetic surgery : JPRAS
2024

Targeting skeletal muscle health with exercise in people with type 1 diabetes: A protocol for HOMET1D, a prospective observational trial with matched controls.

PloS one
2024

Mitochondrial fatty acid beta-oxidation: a possible therapeutic target for skeletal muscle lipotoxicity in peripheral artery disease myopathy.

EXCLI journal
2024

Current research trends on the effect of diabetes mellitus on rotator cuff tendon healing/tendinopathy.

Archives of orthopaedic and trauma surgery
2024

Targeting Molecular Mechanisms of Obesity- and Type 2 Diabetes Mellitus-Induced Skeletal Muscle Atrophy with Nerve Growth Factor.

International journal of molecular sciences
2024

Methods to predict heart failure in diabetes patients.

Expert review of endocrinology &amp; metabolism
2024

Myotonic dystrophy type 1 in South Korea: a comprehensive analysis of cancer and comorbidity risks.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2024

Gene expression alterations of purinergic signaling components in obesity-associated intestinal low-grade inflammation in type 2 diabetes.

Purinergic signalling
2024

Developments in Hand Surgery: Experience from a Tertiary Hospital of Northern Bangladesh.

Mymensingh medical journal : MMJ
2024

Effects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia in large-scale randomised blinded statin trials: an individual participant data meta-analysis.

The lancet. Diabetes &amp; endocrinology
2024

Delayed debridement affects prognosis in patients with purulent flexor tenosynovitis: a retrospective cohort and multivariate analyses.

Archives of orthopaedic and trauma surgery
2024

GC-MS analysis of 4-hydroxyproline: elevated proline hydroxylation in metformin-associated lactic acidosis and metformin-treated Becker muscular dystrophy patients.

Amino acids
2024

The Association between Objectively Measured Physical Activity and the Prevalence of Comorbidities in Lung Transplant Recipients.

Respiration; international review of thoracic diseases
2024

Impact of L-Arginine on diabetes-induced neuropathy and myopathy: Roles of PAI-1, Irisin, oxidative stress, NF-κβ, autophagy and microRNA-29a.

Tissue &amp; cell
2024

Murine MHC-Deficient Nonobese Diabetic Mice Carrying Human HLA-DQ8 Develop Severe Myocarditis and Myositis in Response to Anti-PD-1 Immune Checkpoint Inhibitor Cancer Therapy.

Journal of immunology (Baltimore, Md. : 1950)
2024

Potential Benefits and Risks Associated with the Use of Statins.

Pharmaceutics
2024

Risk of Hemorrhagic Stroke among Patients Treated with High-Intensity Statins versus Pitavastatin-Ezetimibe: A Population Based Study.

The Tohoku journal of experimental medicine
2024

Evaluating different low-density lipoprotein cholesterol thresholds to initiate statin for prevention of cardiovascular diseases in patients with type 2 diabetes mellitus: A target trial emulation study.

Diabetes, obesity &amp; metabolism
2024

RNA therapeutics for treatment of diabetes.

Progress in molecular biology and translational science
2023

Renal manifestations in adults with mitochondrial disease from the mtDNA m.3243A>G pathogenic variant.

Nefrologia
2024

MCC950 Ameliorates Diabetic Muscle Atrophy in Mice by Inhibition of Pyroptosis and Its Synergistic Effect with Aerobic Exercise.

Molecules (Basel, Switzerland)
2025

Incidence, Prevalence, and Outcomes of Hand Manifestations in Patients With Diabetes Mellitus: A Comprehensive Literature Review.

Hand (New York, N.Y.)
2024

Rhabdomyolysis and acute kidney injury potentiated by a drug-drug interaction between cyclosporine, leflunomide, and rosuvastatin in a kidney transplant recipient: A missed opportunity for pharmacist involvement.

Journal of the American Pharmacists Association : JAPhA
2024

A case of exacerbated encephalopathy with stroke-like episodes and lactic acidosis triggered by metformin in a patient with MELAS.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2024

Rheumatological complaints in H syndrome: from inflammatory profiling to target treatment in a case study.

Pediatric rheumatology online journal
2023

Pathogenesis and comprehensive treatment strategies of sarcopenia in elderly patients with type 2 diabetes mellitus.

Frontiers in endocrinology
2025

Structural insights into the interactions of repositioning and known drugs for Alzheimer's disease with hen egg white lysozyme by MM-GBSA.

Journal of biomolecular structure &amp; dynamics
2024

Metabolic and other morbid complications in congenital generalized lipodystrophy type 4.

American journal of medical genetics. Part A
2024

Spontaneous tendon or ligament ruptures in patients undergoing dialysis: First pediatric case report and literature review.

Seminars in dialysis
2024

Ameliorating impact of coenzyme Q10 on the profile of adipokines, cardiomyopathy, and hematological markers correlated with the glucotoxicity sequelae in diabetic rats.

PloS one
2024

Hyperglycaemia is a causal risk factor for upper limb pathologies.

International journal of epidemiology
2024

Neutral lipid storage disease with myopathy: clinicopathological and genetic features of nine Iranian patients.

Neuromuscular disorders : NMD
2023

Improvement of Intestinal Pseudo-Obstruction by Total Parenteral Nutrition in a Young Woman With Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, and Stroke-Like Episodes: A Case Report.

Cureus
2024

Age and sex differences in comorbidities in adult temporomandibular disorders: A cross-sectional study using Korea National Health and Nutrition Examination Survey (KNHANES).

PloS one
2023

Beyond the Cardiovascular Effects of Glucagon-like Peptide-1 Receptor Agonists: Body Slimming and Plaque Stabilization. Are New Statins Born?

Biomolecules
2024

Equilibrative nucleotide transporter ENT3 (SLC29A3): A unique transporter for inherited disorders and cancers.

Experimental cell research
2023

Effects of socioeconomic status on patient-reported outcome after surgically treated trigger finger: a retrospective national registry-based study.

BMJ open
2024

Empagliflozin treatment rescues abnormally reduced Na+ currents in ventricular cardiomyocytes from dystrophin-deficient mdx mice.

American journal of physiology. Heart and circulatory physiology
2024

Myotonic dystrophy type 1 (Steinert disease): 29 years of experience at a tertiary pediatric hospital.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
2024

Changing spectrum of primary pyomyositis in North India.

Tropical doctor
2023

Deletion of the muscle enriched lncRNA Oip5os1 induces atrial dysfunction in male mice with diabetes.

Physiological reports
2024

Identifying Acss1, Mtfp1 and Oxct1 as key regulators and promising biomarkers of sarcopenia in various models.

Gene
2023

Optimal Management of Patients with Phlegmonous Esophagitis: A Systematic Review and Meta-Analysis.

Journal of clinical medicine
2024

Sex-specific associations between skeletal muscle mass and incident diabetes: A population-based cohort study.

Diabetes, obesity &amp; metabolism
2024

A gene therapy targeting medium-chain acyl-CoA dehydrogenase (MCAD) did not protect against diabetes-induced cardiac pathology.

Journal of molecular medicine (Berlin, Germany)
2023

Intra-articular site-specific distribution of advanced glycation end products in the shoulder of patients with diabetes mellitus having rotator cuff tears.

Molecular biology reports
2024

Therapeutic potential of ginsenoside compound K in managing tenocyte apoptosis and extracellular matrix damage in diabetic tendinopathy.

Tissue &amp; cell
2023

55-year-old woman • Myalgias and progressive symmetrical proximal weakness • History of unilateral renal agenesis, type 2 diabetes, and hyperlipidemia • Dx?

The Journal of family practice
2023

Causal influence of muscle weakness on cardiometabolic diseases and osteoporosis.

Scientific reports

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Miopatia e diabetes mellitus.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Miopatia e diabetes mellitus

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ordenadas pelo número de sintomas em comum.

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Heterogeneous phenotype and cardiovascular comorbidities in Swedish patients with spinobulbar muscular atrophy.
    Journal of neurology· 2026· PMID 41513898mais citado
  2. Effectiveness and Safety of Statins in Type 2 Diabetes According to Baseline Cardiovascular Risk : A Target Trial Emulation Study.
    Annals of internal medicine· 2026· PMID 41461087mais citado
  3. Role of LPC 18:1 in the Lipid Metabolic Response to Combined Vitamin D and Resistance Exercise for Protecting Diabetic Skeletal Muscle Function.
    Medicine and science in sports and exercise· 2026· PMID 40903013mais citado
  4. Effects of Diactive-1-Supported Progressive Resistance Training on Body Composition in Youth With Type 1 Diabetes.
    Journal of cachexia, sarcopenia and muscle· 2026· PMID 41854192mais citado
  5. HMGB1: a key molecule linking chronic inflammation to complications in type 2 diabetes mellitus and a target for exercise intervention.
    Frontiers in endocrinology· 2026· PMID 41837146mais citado
  6. Psychosocial implications of rare genetic skin diseases affecting appearance on daily life experiences, emotional state, self-perception and quality of life in adults: a systematic review.
    Orphanet J Rare Dis· 2023· PMID 36823650recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:2596(Orphanet)
  2. OMIM OMIM:500002(OMIM)
  3. MONDO:0010773(MONDO)
  4. GARD:3881(GARD (NIH))
  5. Variantes catalogadas(ClinVar)
  6. Busca completa no PubMed(PubMed)
  7. Q55782717(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Miopatia e diabetes mellitus
Compêndio · Raras BR

Miopatia e diabetes mellitus

ORPHA:2596 · MONDO:0010773
CID-10
G71.3 · Miopatia mitocondrial não classificada em outra parte
CID-11
Início
Adolescent, Adult, Childhood, Infancy, Neonatal
MedGen
UMLS
C1839028
Repurposing
40 candidatos
acarboseglucosidase inhibitor
acetohexamideATP channel blocker
alogliptindipeptidyl peptidase inhibitor
+17 outros
EuropePMC
Wikidata
Evidência
🥇 Rev. sistemática
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades